Medicine chapters

Dialysis and renal replacement therapy (indications AEIOU)

What the kidney does and which of its jobs dialysis can and cannot replace, how haemodialysis, haemofiltration and peritoneal dialysis work, the AEIOU indications, how often each is done, their complications, and transplantation.

UHS PGET syllabus: Nephrology (8 MCQs), Renal replacement therapy: endocrine and non-endocrine functions, management of symptoms caused by CKD; dialysis: rationale of use, indications (A, E, I, O, U), frequencyUpdated October 2026
In 30 seconds
  • Dialysis replaces the kidney's excretory jobs (removing urea, potassium, acid and water) but not its endocrine jobs (erythropoietin, calcitriol, renin), so dialysis patients still need ESAs and active vitamin D.
  • Urgent indications are AEIOU: refractory Acidosis, Electrolytes (hyperkalaemia), Intoxication, fluid Overload, Uraemic complications (pericarditis, encephalopathy).
  • Haemodialysis is usually 4–5 hours, three times a week via an AV fistula; CAPD uses 3–5 exchanges a day; its main complication is peritonitis (Staph. epidermidis). Transplant is the best RRT.
On this page

Overview

Renal replacement therapy (RRT) means treatments that take over the work of failed kidneys: haemodialysis, haemofiltration, peritoneal dialysis and kidney transplantation. It is used for AKI with dangerous complications and for end-stage kidney disease (CKD stage G5).

To understand what RRT can and cannot do, start with what a healthy kidney does.

Functions of the kidney

Non-endocrine (excretory and regulatory) functions

FunctionWhat failure causesReplaced by dialysis?
Excretion of nitrogenous waste (urea, creatinine, urate) and drugsUraemia, drug toxicityYes, partly
Water and sodium balanceOedema, hypertension, pulmonary oedemaYes (ultrafiltration)
Potassium balanceHyperkalaemiaYes
Acid–base balance (H+ and ammonium excretion, bicarbonate regeneration)Metabolic acidosisYes (bicarbonate or lactate in dialysate)
Phosphate excretion, calcium balanceHyperphosphataemiaPartly (binders still needed)
Gluconeogenesis; breakdown of insulin and other peptide hormonesHypoglycaemia risk, lower insulin needs in diabeticsNot really

Endocrine functions

HormoneMade where / howEffect of lossReplacement
ErythropoietinPeritubular interstitial cells, in response to hypoxiaNormocytic anaemiaESA (epoetin, darbepoetin) + iron
Calcitriol (1,25-dihydroxyvitamin D)1α-hydroxylase in the proximal tubuleLow calcium, secondary hyperparathyroidism, renal bone diseaseAlfacalcidol or calcitriol
ReninJuxtaglomerular cells (afferent arteriole)Overactivity contributes to hypertension in CKDACE inhibitors/ARBs to block it
Prostaglandins, kininsLocallyLoss of protection of renal blood flow—
High-yield

Dialysis replaces only the excretory and regulatory functions. A dialysis patient still needs erythropoietin, active vitamin D, phosphate binders and BP control. A successful transplant replaces all functions, endocrine included.

Managing the symptoms of CKD (before and alongside dialysis)

ProblemManagement
AnaemiaCorrect iron (IV iron), then ESA; target Hb 100–120 g/L
Bone disease / hyperphosphataemiaLow-phosphate diet, phosphate binders with meals, alfacalcidol, cinacalcet, parathyroidectomy if refractory
HyperkalaemiaLow-potassium diet, stop K+-retaining drugs, binders, correct acidosis
AcidosisOral sodium bicarbonate
Fluid overload, hypertensionSalt and fluid restriction, loop diuretics, antihypertensives (ACE inhibitor/ARB)
Nausea, anorexiaAntiemetics, dietitian review; persistent symptoms suggest the need for dialysis
PruritusControl phosphate and PTH, emollients for dry skin, antihistamines, adequate dialysis
Restless legs, crampsCorrect iron deficiency, adequate dialysis
MalnutritionNormal protein intake, dietitian, avoid excessive protein restriction
Dyslipidaemia, CV riskStatin, stop smoking
GoutColchicine for attacks; allopurinol at reduced dose (avoid NSAIDs)
Psychological and end-of-life careShared decisions; conservative care is a valid choice for frail patients

Rationale of dialysis: how it works

  • Diffusion: blood and dialysate flow on opposite sides of a semipermeable membrane (in the dialyser or the peritoneum). Small solutes (urea, creatinine, potassium) move from high to low concentration. Countercurrent flow keeps the gradient steep. Bicarbonate moves from dialysate into blood to correct acidosis.
  • Ultrafiltration: water is pushed or pulled across the membrane by pressure (haemodialysis) or osmosis (glucose in peritoneal dialysis fluid).
  • Convection: solutes are dragged along with the water ("solvent drag"); this is the main mechanism of haemofiltration and clears larger "middle molecules" such as β2-microglobulin better.
  • Cells and large proteins do not cross the membrane.
High-yield

Dialysis removes small solutes well but middle molecules poorly; build-up of β2-microglobulin causes dialysis amyloidosis and carpal tunnel syndrome after years of treatment.

The aims are to remove nitrogenous waste, keep electrolytes normal, correct acidosis and keep the patient at a normal fluid volume ("dry weight").

Indications for dialysis

Urgent indications (mainly in AKI): AEIOU

LetterIndicationExamples
AAcidosisSevere metabolic acidosis not corrected by medical treatment
EElectrolytesHyperkalaemia that persists despite medical treatment, especially with ECG changes
IIntoxicationDialysable poisons and drugs: lithium, salicylate, methanol, ethylene glycol, theophylline; drugs causing AKI such as gentamicin
OOverloadPulmonary oedema not responding to diuretics
UUraemiaUraemic pericarditis or tamponade, encephalopathy (confusion, fits), uraemic bleeding, symptomatic uraemia
Memory hook

AEIOU – the five vowels: Acid, Electrolytes, Intoxication, Overload, Uraemia.

Exam trap

A low eGFR alone (for example 20 mL/min) is not an indication. Dialysis is started for symptoms or complications, or when eGFR is very low (around 10).

Chronic dialysis in ESKD

  • Usually started when eGFR is around 10 mL/min/1.73 m² or earlier if there are uraemic symptoms, refractory fluid overload, hyperkalaemia, acidosis or malnutrition.
  • Starting early has not been shown to improve survival; the timing is a shared decision.
  • Some frail patients choose conservative care without dialysis.

Haemodialysis

Access

TypeNotes
Arteriovenous fistula (AVF)Best: radial or brachial artery joined to the cephalic vein (radiocephalic at the wrist), in the non-dominant arm; needs several weeks to mature; lowest infection and clotting rates
AV graftSynthetic tube; when veins are poor (e.g. diabetes, vascular disease)
Tunnelled central venous catheterInternal jugular (or femoral); usable at once; high risk of bacteraemia, thrombosis and central venous stenosis
Temporary non-tunnelled catheterFor urgent dialysis (jugular, femoral, subclavian)
Exam trap

In a patient with CKD who may need dialysis, do not cannulate or take blood from the non-dominant forearm veins. They are needed for a future fistula. Do not take BP or compress the fistula arm (risk of thrombosis).

Frequency and adequacy

  • Standard: 4–5 hours, three times a week. Blood flows at about 250–450 mL/min.
  • More frequent or longer sessions improve wellbeing and BP but are harder to sustain.
  • Fluid gained between sessions = intake minus losses. Patients limit fluid to keep interdialytic weight gain low.
  • Adequacy: urea reduction ratio (URR) above 65% per session, or Kt/V (K = dialyser clearance, t = time, V = urea distribution volume).
  • Signs of under-dialysis: itch, fatigue, poor sleep, restless legs, neuropathy, pericarditis.
Worked example: urea reduction ratio

Pre-dialysis urea 25 mmol/L; post-dialysis urea 8 mmol/L
URR = (25 − 8) ÷ 25 × 100 = 68%
Above 65% → adequate session

Worked example: interdialytic weight gain

Anuric patient drinks 2 L a day; 2 days between sessions
Gain ≈ 2 L × 2 days = 4 L ≈ 4 kg to remove at the next session

Complications of haemodialysis

  • Intradialytic hypotension (fluid removed faster than it refills the circulation): cramps, dizziness.
  • Dialysis disequilibrium syndrome: at the first sessions in very uraemic patients, blood urea falls faster than brain urea, water moves into the brain → headache, vomiting, confusion, fits (cerebral oedema). Prevent with short, gentle, repeated sessions.
  • Access problems: fistula thrombosis, stenosis, bleeding, aneurysm; steal syndrome.
  • Infection: catheter bacteraemia (Staph. aureus), endocarditis, septic arthritis, vertebral osteomyelitis; blood-borne viruses (hepatitis B and C).
  • Dialysis-related amyloidosis (β2-microglobulin) after years: carpal tunnel syndrome, arthropathy, bone cysts.
  • Others: air embolism, haemolysis, reactions to the dialyser, anticoagulation bleeding, hyperkalaemia between sessions.

Haemofiltration and haemodiafiltration

  • Haemofiltration: no dialysate; plasma water and solutes are removed by convection through a high-flux membrane, and a replacement fluid is infused.
  • Continuous venovenous haemofiltration (CVVHF): runs all day through a dual-lumen central catheter; gentle, so preferred in haemodynamically unstable ITU patients with AKI.
  • Haemodiafiltration combines diffusion and convection to clear middle molecules (β2-microglobulin).

Peritoneal dialysis (PD)

How it works

  • A soft Tenckhoff catheter is tunnelled into the peritoneal cavity.
  • Dialysate (containing glucose or icodextrin as the osmotic agent, and lactate as buffer) is run in, left to dwell, then drained.
  • The peritoneal membrane acts as the semipermeable membrane; urea, creatinine and potassium diffuse into the fluid, and water follows the glucose by osmosis (stronger glucose bags remove more water).

Types and frequency

  • CAPD (continuous ambulatory PD): fluid in the abdomen at all times; 3–5 exchanges a day of 1.5–3 L, each taking about 20–40 minutes, done by the patient at home with a sterile technique.
  • APD (automated PD): a machine performs exchanges overnight while the patient sleeps.

Advantages and drawbacks

PD advantagesPD drawbacks / contraindications
Done at home; independence, travelNeeds a motivated patient (or carer) and clean home
No vascular access or anticoagulationUnsuitable with major abdominal surgery, adhesions, hernias, stomas
Gentle, steady removal; better preserves residual renal functionLess efficient; fails when residual function is lost
Useful in children and where machines are scarceGlucose absorption causes weight gain and hyperglycaemia

Complications of PD

High-yield

A cloudy bag with abdominal pain in a CAPD patient is peritonitis until proved otherwise; the usual organism is the skin commensal Staph. epidermidis.

  • Peritonitis (about one episode every 2 patient-years): cloudy effluent (>100 white cells/mm³), abdominal pain, fever. Commonest organism: Staphylococcus epidermidis (coagulase-negative staph), then Gram-negatives, Staph. aureus, rarely TB or fungi. Treat with intraperitoneal antibiotics; fungal peritonitis needs catheter removal.
  • Exit site and tunnel infections.
  • Catheter problems: poor drainage, often from constipation; displacement.
  • Raised intra-abdominal pressure: hernias, fluid leak, hydrothorax (pleural effusion, usually right-sided), scrotal swelling.
  • Metabolic: hyperglycaemia, weight gain, hypertriglyceridaemia (glucose load); protein loss into the dialysate causing hypoalbuminaemia; hypokalaemia.
  • Encapsulating sclerosing peritonitis: rare, serious late complication with thickened peritoneum and recurrent bowel obstruction.
  • Failure of the membrane (ultrafiltration failure) over years; switch to haemodialysis.

Haemodialysis vs peritoneal dialysis

FeatureHaemodialysisPeritoneal dialysis
MembraneSynthetic dialyserPatient's peritoneum
WhereHospital or unit (home possible)Home
Frequency4–5 h, 3 times weeklyCAPD 3–5 exchanges daily; APD nightly
AccessAV fistula, graft or catheterTenckhoff catheter
AnticoagulationNeeded (heparin)Not needed
Fluid and dietStricter fluid and potassium limitsMore liberal
Main infectionsCatheter bacteraemia (Staph. aureus)Peritonitis (Staph. epidermidis)
Best forUnstable fluid status, failed PD, abdominal problemsIndependent patients, children, those with poor vascular access or heart disease

Kidney transplantation

  • The best form of RRT for suitable patients: better survival and quality of life, and it restores endocrine functions. Pre-emptive living donor transplantation (before dialysis) gives the best results.
  • The graft is placed in the iliac fossa; native kidneys are usually left.
  • Needs ABO compatibility, a negative cross-match, and good HLA matching (A, B, DR).
  • Lifelong immunosuppression (tacrolimus, mycophenolate, steroids), with risks of infection (CMV, BK virus, Pneumocystis), skin cancer and post-transplant lymphoproliferative disease, diabetes and drug nephrotoxicity.
  • Rejection: hyperacute (preformed antibodies, minutes), acute (weeks to months, treatable), chronic (gradual decline).
  • Some diseases recur in the graft (FSGS, IgA nephropathy, MPGN).
Exam focus

Expect: the AEIOU list and what is not an indication (eGFR of 20 alone); which kidney functions dialysis cannot replace (erythropoietin, calcitriol) and the drugs that replace them; diffusion, ultrafiltration and convection; haemodialysis 4–5 hours three times a week with a radiocephalic fistula in the non-dominant arm; CVVHF in unstable ITU patients; CAPD exchanges and complications (peritonitis with Staph. epidermidis, hernias, pleural effusion, hyperglycaemia, protein loss, hypertriglyceridaemia); dialysis disequilibrium; β2-microglobulin amyloid and carpal tunnel; under-dialysis symptoms; and transplantation as the best RRT.

Quick revision

  • Dialysis replaces excretory functions, not EPO or calcitriol.
  • AEIOU: acidosis, electrolytes (K+), intoxication, overload, uraemia.
  • Dialysable: lithium, salicylate, methanol, ethylene glycol.
  • Chronic dialysis around eGFR 10 or for symptoms; eGFR alone is not an indication.
  • HD: 4–5 h × 3/week; radiocephalic AVF, non-dominant arm; URR >65%.
  • HD problems: hypotension, disequilibrium, access infection, β2-microglobulin amyloid.
  • CAPD: 3–5 exchanges/day; peritonitis (Staph. epidermidis), hernia, hydrothorax, hyperglycaemia, protein loss.
  • CVVHF for unstable ITU patients. Transplant is the best RRT.

Written by The House Job from standard references (Kumar and Clark's Clinical Medicine).

FAQ

Why do dialysis patients still need erythropoietin injections?

Dialysis only cleans the blood and removes water; it cannot make hormones, so the erythropoietin the kidney used to produce must be given as a drug.

What is the difference between dialysis and haemofiltration?

Dialysis clears solutes mainly by diffusion into a dialysate, while haemofiltration removes plasma water and dissolved solutes by convection and replaces it with clean fluid.

What does a cloudy peritoneal dialysis bag mean?

Peritonitis until proven otherwise; the fluid should be sent for cell count and culture and intraperitoneal antibiotics started.

Why is the first dialysis session kept short in a very uraemic patient?

Removing urea too quickly lowers blood urea faster than brain urea, drawing water into the brain and causing disequilibrium with headache, confusion or fits.